Imidazolopyridines and methods of making and using the same
申请人:Lee Wen-Cherng
公开号:US20060135517A1
公开(公告)日:2006-06-22
Compounds of formula I possess unexpectedly high affinity for Alk 5 and/or Alk 4, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including fibrotic disorders. In one embodiment, the invention features a compound of formula I:
IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME
申请人:Biogen Idec MA Inc.
公开号:EP1546112A2
公开(公告)日:2005-06-29
EP1546112A4
申请人:——
公开号:EP1546112A4
公开(公告)日:2006-06-07
[EN] IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME<br/>[FR] IMIDAZOLOPYRIDINES, PROCEDES DE FABRICATION ET METHODES D'UTILISATION
申请人:BIOGEN INC
公开号:WO2004021989A2
公开(公告)日:2004-03-18
Compounds of formula I possess unexpectedly high affinity for Alk 5 and/or Alk 4, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including fibrotic disorders. In one embodiment, the invention features a compound of formula I:
[EN] PYRIMIDINYLIMIDAZOLES AS TGF-BETA INHIBITORS<br/>[FR] PYRIMIDINYLIMIDAZOLES UTILISES COMME INHIBITEURS DE TGF-BETA
申请人:BIOGEN IDEC INC
公开号:WO2006026306A1
公开(公告)日:2006-03-09
Compounds of formula (I) possess unexpectedly high affinity for Alk 5 and/or Alk 4, and can be useful as antagonists thereof for preventing and/or treating numerous diseases, including fibrotic disorders. The invention features a compound of the general formula (I) and uses thereof.